Jason Coloma V.
Director at Braveheart Bio; Chief Executive Officer at Maze Therapeutics. Based in South San Francisco, California.
- Rank
- 5362nd of 14,452
- Companies held
- 2
- Largest holding
- MAZE, 90.6% of total
- Latest SEC filing
- Nov 2, 2026
- Listed but not counted
- $17.6M
What the $19.2M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Maze Therapeutics MAZE Common Stock | Coloma Family Trust | 287,171 | $32.43 | $9.3M | 48.4% | Form 4, Jul 1, 2026 |
| Maze Therapeutics MAZE Common Stock | Coloma Family Trust | 186,901 | $32.43 | $6.1M | 31.5% | Form 4, Nov 2, 2026 |
| Braveheart Bio BRVE Common Stock | Through The Coloma 2021 Irrevocable Family Trust f/b/o Miles Coloma u/a/d 9/20/2021 | 93,607 | $19.27 | $1.8M | 9.4% | Form 3, Aug 5, 2026 |
| Maze Therapeutics MAZE Common Stock | Directly | 27,362 | $32.43 | $887K | 4.6% | Form 4, Oct 1, 2026 |
| Maze Therapeutics MAZE Common Stock | The Coloma 2021 Irrevocable Trust | 23,337 | $32.43 | $757K | 3.9% | Form 4, Jul 1, 2026 |
| Maze Therapeutics MAZE Common Stock | The Coloma 2021 Irrevocable Trust | 12,965 | $32.43 | $420K | 2.2% | Form 4, Nov 2, 2026 |
Share counts are the amounts Jason Coloma V. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Jason Coloma V.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Braveheart Bio BRVE Common Stock | Through Westport Meridian Capital LP Held by an investment fund or partnership | 913,242 | $19.27 | $17.6M | — | Form 3, Aug 5, 2026 |
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Sold | MAZE | 2,257 | $30.12 | $68K | View |
| Nov 2, 2026 | Sold | MAZE | 336 | $30.91 | $10K | View |
| Nov 2, 2026 | Sold | MAZE | 26,563 | $30.10 | $799K | View |
| Nov 2, 2026 | Sold | MAZE | 5,345 | $31.05 | $166K | View |
| Oct 1, 2026 | Sold | MAZE | 2,593 | $27.02 | $70K | View |
| Oct 1, 2026 | Sold | MAZE | 31,908 | $27.02 | $862K | View |
| Sep 3, 2026 | Sold | MAZE | 129 | $25.77 | $3K | View |
| Sep 3, 2026 | Sold | MAZE | 11,282 | $26.01 | $293K | View |
| Sep 2, 2026 | Sold | MAZE | 1,375 | $27.12 | $37K | View |
| Sep 2, 2026 | Sold | MAZE | 9,852 | $26.38 | $260K | View |
| Sep 1, 2026 | Sold | MAZE | 2,593 | $26.31 | $68K | View |
| Sep 1, 2026 | Sold | MAZE | 31,908 | $26.29 | $839K | View |
| Aug 3, 2026 | Sold | MAZE | 2,439 | $26.71 | $65K | View |
| Aug 3, 2026 | Sold | MAZE | 154 | $27.09 | $4K | View |
| Aug 3, 2026 | Sold | MAZE | 30,304 | $26.71 | $809K | View |
| Aug 3, 2026 | Sold | MAZE | 1,604 | $27.09 | $43K | View |
| Jul 1, 2026 | Sold | MAZE | 1,597 | $30.44 | $49K | View |
| Jul 1, 2026 | Sold | MAZE | 2,593 | $29.98 | $78K | View |
| Jul 1, 2026 | Sold | MAZE | 30,311 | $29.95 | $908K | View |
| Jun 23, 2026 | Sold | MAZE | 23,865 | $26.05 | $622K | View |
| Jun 22, 2026 | Sold | MAZE | 1,953 | $26.00 | $51K | View |
| Jun 22, 2026 | Sold | MAZE | 2,040 | $26.00 | $53K | View |
| Jun 1, 2026 | Sold | MAZE | 6,090 | $26.20 | $160K | View |
| Jun 1, 2026 | Sold | MAZE | 553 | $26.24 | $15K | View |
| May 26, 2026 | Sold | MAZE | 25,582 | $26.02 | $666K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 5359 | Ronald M. Lombardi Chief Executive Officer, Prestige Consumer Healthcare. Tarrytown, NY | $19.3M |
| 5360 | Charles Lynn Hamilton Chief Site Development Officer, Fermi. Amarillo, TX | $19.3M |
| 5361 | Shailesh Jejurikar Chairman, President and CEO, The Procter & Gamble. Cincinnati, OH | $19.3M |
| 5362 | Jason Coloma V. Director, Braveheart Bio. South San Francisco, CA | $19.2M |
| 5363 | Brian E. O.'Toole CEO and President, BlackSky Technology. Herndon, VA | $19.2M |
| 5364 | David R. Lukes President & CEO, Curbline Properties. New York, NY | $19.2M |
| 5365 | John Drayton Wise Chief Commercial Officer, Insmed. Bridgewater, NJ | $19.2M |
Other Braveheart Bio insiders
All BRVE insiders- Travis Murdoch$141MCEO and President. #1160 overall
- David I. Malek$14.9MDirector. #6476 overall
- Christopher Viehbacher$14.6MDirector. #4810 overall
- James Paul Rickey$11.8MChief Financial Officer. #7757 overall
- Michele A. Anderson$6.4MChief Development Officer. #12189 overall
Questions
How much stock does Jason Coloma V. own?
Jason Coloma V. holds $19,242,585 in listed stock based on SEC filings and current prices, mostly Maze Therapeutics (MAZE). That ranks 5362nd on the Stock Rich List.
Is this Jason Coloma V.'s net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Jason Coloma V. last buy or sell stock?
The most recent open-market trade on file is a sale of 2,257 MAZE shares on Nov 2, 2026 at $30.12.